Tweet
<img alt="" height="1" width="1" />
Amgen Gets Positive Opinion In EU For Osteoporosis Drug
Wall Street Journal
Amgen Inc. (AMGN) said Friday that the Committee for Medicinal Products for Human Use of the European Medicines Agency has given a positive opinion for the marketing authorization of its osteoporosis drug candidate Prolia, formerly known as denosumab. ...
Amgen's Prolia moves closer to European approvalBusinessWeek
Market Report -- In Play (AMGN)MSN Money
Amgen's D-mab one step closer to EU approvalFierceBiotech
Reuters UK -PR Newswire (press release)
all 43 news articles »
More...